Achieve Life Sciences (ACHV) Financials: Revenue & Earnings
ACHV$6.80-0.13 -1.88%
$699.73M
Market Cap
—
P/E
—
Forward P/E
—
Score
Achieve Life Sciences (ACHV) Financials: Revenue & Earnings
ACHV price $6.80 -0.13 -1.88%
- Ticker
- ACHV
- Price
- $6.80
- Change
- -0.13 -1.88%
- Market cap ?
- $699.73M
- Beta ?
- 2.31
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
ACHV fair value $2.20. Price $6.80. Price is 209% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.24M. Growth 13.97%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.90M. Net debt -5.97M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.20 | — | 10.65M |
| 2026-08-11 | -0.80 | -0.16 | — | — |
| 2026-05-12 | -0.19 | -0.30 | — | — |
| 2026-03-24 | -0.28 | -0.27 | — | — |
| 2025-11-06 | -0.28 | -0.24 | — | — |
| 2025-08-07 | -0.37 | -0.37 | — | — |
| 2025-05-13 | -0.37 | -0.37 | — | — |
| 2025-03-11 | -0.36 | -0.30 | — | — |
| 2024-11-07 | -0.36 | -0.26 | — | — |
| 2024-08-13 | -0.25 | -0.22 | — | — |
| 2024-05-09 | -0.26 | -0.24 | — | — |
| 2024-03-28 | -0.26 | -0.32 | — | — |
| 2023-11-09 | -0.34 | -0.34 | — | — |
| 2023-08-14 | -0.43 | -0.41 | — | — |
| 2023-05-09 | -0.50 | -0.65 | — | — |
| 2023-03-16 | -0.83 | -0.90 | — | 100.00K |
| 2022-11-14 | -1.35 | -1.10 | — | 62.50K |
| 2022-08-11 | -1.08 | -0.79 | — | 62.50K |
| 2022-05-12 | -0.80 | -0.82 | — | — |
| 2022-03-10 | -0.76 | -0.73 | — | 50.00K |
| 2021-11-09 | -0.71 | -1.09 | — | — |
| 2021-08-11 | -1.53 | -1.23 | — | — |
| 2021-05-13 | -1.30 | -0.78 | — | — |
| 2021-03-11 | -1.11 | -1.27 | — | — |
| 2020-11-12 | -1.14 | -1.30 | — | — |
| 2020-08-06 | -1.68 | -3.80 | — | — |
| 2020-05-14 | -2.20 | -2.40 | — | — |
| 2020-03-13 | -6.00 | -5.40 | — | — |
| 2019-11-06 | -9.00 | -4.40 | — | — |
| 2019-08-08 | -10.00 | -6.60 | — | — |
| 2019-05-15 | -17.60 | -12.60 | — | — |
| 2019-03-14 | -11.00 | -12.80 | — | — |
| 2018-11-07 | -14.20 | -25.60 | — | — |
| 2018-08-08 | -36.40 | — | — | — |
| 2018-05-09 | -48.00 | — | — | — |
| 2018-03-01 | -64.00 | — | — | — |
| 2017-11-09 | -180.00 | — | — | — |
| 2017-07-31 | -219.03 | — | — | — |
| 2017-05-15 | -239.03 | — | — | — |
| 2017-02-23 | -428.18 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Halladay Benjamin | Buy | 200.00K | $7.01 | 1.40M |
| 2026-10-05 | Halladay Benjamin | Buy | 200.00K | — | — |
| 2026-10-05 | Halladay Benjamin | Other | 0 | — | — |
| 2026-08-19 | Stewart Richard Alistair | Sell | 20.63K | $8.49 | 175.18K |
| 2026-07-27 | Sellig Thomas | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Sellig Thomas | Buy | 16.70K | — | — |
| 2026-07-27 | Martin Christopher Nathan | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Martin Christopher Nathan | Buy | 16.70K | — | — |
| 2026-07-27 | Royston Aaron | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Royston Aaron | Buy | 16.70K | — | — |
| 2026-07-27 | Waldman Reid Alexander | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Waldman Reid Alexander | Buy | 16.70K | — | — |
| 2026-07-27 | Stewart Richard Alistair | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Stewart Richard Alistair | Buy | 16.70K | — | — |
| 2026-07-27 | Farrow Jeffrey S | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Farrow Jeffrey S | Buy | 16.70K | — | — |
| 2026-07-27 | Phelan Nancy R. | Buy | 25.00K | $6.18 | 154.50K |
| 2026-07-27 | Phelan Nancy R. | Buy | 16.70K | — | — |
| 2026-05-29 | Waldman Reid Alexander | Buy | 47.25K | $5.24 | 247.59K |
| 2026-05-29 | Farrow Jeffrey S | Buy | 47.25K | $5.24 | 247.59K |
| 2026-05-29 | Waldman Reid Alexander | Other | 0 | — | — |
| 2026-05-29 | Farrow Jeffrey S | Other | 0 | — | — |
| 2026-05-11 | Martin Christopher Nathan | Buy | 47.25K | $5.59 | 264.13K |
| 2026-05-11 | Martin Christopher Nathan | Other | 0 | — | — |
| 2026-04-18 | Goldberg Andrew D. | Buy | 11.71M | — | — |
| 2026-04-18 | Goldberg Andrew D. | Buy | 3.60M | $4.25 | 15.31M |
| 2026-04-18 | Goldberg Andrew D. | Buy | 1.80M | — | — |
| 2026-04-18 | Goldberg Andrew D. | Other | 0 | — | — |
| 2026-04-17 | Royston Aaron | Other | 0 | — | — |
| 2026-04-17 | TPG GP A, LLC | Other | 0 | — | — |
| 2026-04-17 | TPG GP A, LLC | Other | 6.88M | $3.51 | 24.14M |
| 2026-04-17 | Iancovici Lucian | Other | 0 | — | — |
| 2026-01-28 | Rubinstein Mark Lawrence | Buy | 180.00K | $4.36 | 784.80K |
| 2026-01-28 | Oki Mark K | Buy | 180.00K | $4.36 | 784.80K |
| 2026-01-28 | Xinos Jaime | Buy | 180.00K | $4.36 | 784.80K |
| 2026-01-28 | Donnelly Craig | Buy | 180.00K | $4.36 | 784.80K |
| 2026-01-28 | Stewart Richard Alistair | Buy | 645.00K | $4.36 | 2.81M |
| 2026-01-28 | Wan Jerry | Buy | 70.30K | $4.36 | 306.51K |
| 2026-01-01 | Rubinstein Mark Lawrence | Other | 0 | — | — |
| 2026-01-01 | Rubinstein Mark Lawrence | Other | 47.00K | $4.52 | 212.44K |
| 2026-01-01 | Rubinstein Mark Lawrence | Other | 50.00K | $3.10 | 155.00K |
| 2025-12-04 | Atkisson Erik | Buy | 250.00K | $4.78 | 1.20M |
| 2025-10-20 | Atkisson Erik | Other | 0 | — | — |
| 2025-10-01 | Donnelly Craig | Buy | 50.00K | $3.10 | 155.00K |
| 2025-09-18 | Oki Mark K | Buy | 168.00K | — | — |
| 2025-09-18 | Oki Mark K | Sell | 50.06K | $2.92 | 146.18K |
| 2025-09-18 | Oki Mark K | Sell | 168.00K | — | — |
| 2025-09-18 | Stewart Richard Alistair | Buy | 297.50K | — | — |
| 2025-09-18 | Stewart Richard Alistair | Sell | 129.50K | $2.92 | 378.14K |
| 2025-09-18 | Stewart Richard Alistair | Sell | 157.50K | — | — |
| 2025-09-08 | Donnelly Craig | Other | 0 | — | — |
| 2025-09-08 | Donnelly Craig | Other | 22.50K | $4.55 | 102.38K |
| 2025-09-08 | Donnelly Craig | Other | 25.00K | $4.53 | 113.25K |
| 2025-09-04 | Oki Mark K | Sell | 168.00K | — | — |
| 2025-09-04 | Stewart Richard Alistair | Sell | 157.50K | — | — |
| 2025-09-04 | Wan Jerry | Buy | 34.10K | — | — |
| 2025-09-04 | Wan Jerry | Sell | 9.60K | — | — |
| 2025-09-04 | Wan Jerry | Sell | 14.07K | $2.77 | 38.97K |
| 2025-09-04 | Wan Jerry | Sell | 24.50K | — | — |
| 2025-09-04 | KING THOMAS BRAXTON | Buy | 455.00K | — | — |
| 2025-09-04 | KING THOMAS BRAXTON | Sell | 139.86K | $2.77 | 387.41K |
| 2025-09-04 | KING THOMAS BRAXTON | Sell | 455.00K | — | — |
| 2025-09-04 | JACOBS CINDY | Buy | 110.00K | — | — |
| 2025-09-04 | JACOBS CINDY | Sell | 27.63K | $2.77 | 76.53K |
| 2025-09-04 | JACOBS CINDY | Sell | 26.00K | — | — |
| 2025-09-04 | JACOBS CINDY | Sell | 84.00K | — | — |
| 2025-09-04 | Xinos Jaime | Buy | 69.00K | — | — |
| 2025-09-04 | Xinos Jaime | Sell | 20.00K | — | — |
| 2025-09-04 | Xinos Jaime | Sell | 20.85K | $2.77 | 57.77K |
| 2025-09-04 | Xinos Jaime | Sell | 49.00K | — | — |
| 2025-06-06 | Slaoui Kristen B. | Buy | 31.50K | $3.83 | 120.64K |
| 2025-06-06 | Phelan Nancy R. | Buy | 31.50K | $3.83 | 120.64K |
| 2025-06-06 | Sellig Thomas | Buy | 31.50K | $3.83 | 120.64K |
| 2025-06-06 | Martell Bridget A | Buy | 31.50K | $3.83 | 120.64K |
| 2025-06-06 | KING THOMAS BRAXTON | Buy | 31.50K | $3.83 | 120.64K |
| 2025-06-06 | Duty Stuart | Buy | 31.50K | $3.83 | 120.64K |
| 2025-03-17 | Oki Mark K | Buy | 10.00K | $2.89 | 28.89K |
| 2025-03-17 | Stewart Richard Alistair | Buy | 10.00K | $2.86 | 28.60K |
| 2025-01-28 | Wan Jerry | Buy | 48.00K | — | — |
| 2025-01-28 | Xinos Jaime | Buy | 100.00K | — | — |
| 2025-01-28 | JACOBS CINDY | Buy | 130.00K | — | — |
| 2025-01-13 | Slaoui Kristen B. | Buy | 47.25K | $3.32 | 156.87K |
| 2025-01-13 | Phelan Nancy R. | Buy | 47.25K | $3.32 | 156.87K |
| 2025-01-13 | Stewart Richard Alistair | Buy | 157.50K | — | — |
| 2025-01-13 | Stewart Richard Alistair | Buy | 67.50K | $3.32 | 224.10K |
| 2025-01-13 | KING THOMAS BRAXTON | Buy | 455.00K | — | — |
| 2025-01-13 | KING THOMAS BRAXTON | Buy | 195.00K | $3.32 | 647.40K |
| 2025-01-13 | Xinos Jaime | Buy | 20.00K | $3.32 | 66.40K |
| 2025-01-06 | Slaoui Kristen B. | Other | 0 | — | — |
| 2025-01-06 | Phelan Nancy R. | Other | 0 | — | — |
| 2024-12-06 | Xinos Jaime | Buy | 30.00K | $4.52 | 135.60K |
| 2024-12-06 | Oki Mark K | Buy | 168.00K | — | — |
| 2024-12-06 | Oki Mark K | Buy | 72.00K | $4.52 | 325.44K |
| 2024-12-05 | Oki Mark K | Other | 0 | — | — |
| 2024-10-15 | Xinos Jaime | Other | 0 | — | — |
| 2024-10-15 | Xinos Jaime | Other | 1.00K | $67.40 | 67.40K |
| 2024-10-15 | Xinos Jaime | Other | 10.00K | $11.20 | 112.00K |
| 2024-10-15 | Xinos Jaime | Other | 22.50K | $8.26 | 185.85K |
| 2024-10-15 | Xinos Jaime | Other | 2.00K | $28.40 | 56.80K |
| 2024-10-15 | Xinos Jaime | Other | 32.50K | $4.90 | 159.25K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 119, holders +33 vs prior quarter. Ownership 88.57%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 7.61M | 7.61M | New | 49.72M |
| TPG GP A, LLC | 6.88M | 6.88M | New | 44.91M |
| VENBIO PARTNERS LLC | 5.91M | 5.91M | New | 38.62M |
| LOGOS GLOBAL MANAGEMENT LP | 5.42M | 5.42M | New | 35.43M |
| BLACKROCK, INC. | 5.27M | 4.83M | +1099.93% | 34.43M |
| FRANKLIN TEMPLETON INC | 4.95M | 584.03K | +13.37% | 32.34M |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.95M | 4.95M | New | 32.34M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.14M | 1.94M | +87.82% | 27.04M |
| PROPEL BIO MANAGEMENT, LLC | 4.03M | 247.59K | +6.54% | 26.34M |
| MARSHALL WACE, LLP | 3.77M | 2.75M | +269.90% | 24.62M |
| STATE STREET CORP | 2.95M | 2.69M | +1057.57% | 19.23M |
| VIVO CAPITAL, LLC | 2.75M | 2.75M | New | 17.96M |
| JUPITER TOPCO LLC | 2.75M | 2.75M | New | 17.96M |
| VENROCK ADVISER, LLC | 2.75M | 2.75M | New | 17.96M |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.22M | 2.22M | New | 14.50M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.06M | 1.44M | +231.21% | 13.47M |
| ALYESKA INVESTMENT GROUP, L.P. | 1.93M | 1.93M | New | 12.57M |
| SIMPLIFY ASSET MANAGEMENT INC. | 1.43M | 247.59K | +20.90% | 9.35M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.43M | 1.43M | New | 9.32M |
| CAPTION MANAGEMENT, LLC | 1.18M | 1.18M | +851711.59% | 7.68M |
| LPL FINANCIAL LLC | 902.25K | 173.81K | +23.86% | 5.89M |
| NORTHERN TRUST CORP | 743.76K | 519.02K | +230.94% | 4.86M |
| SPRUCE STREET CAPITAL LP | 736.64K | 736.64K | New | 4.81M |
| VANGUARD FIDUCIARY TRUST CO | 593.75K | 277.57K | +87.79% | 3.88M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 577.50K | 535.20K | +1265.25% | 3.77M |
Earnings and financials
Achieve Life Sciences, Inc. (ACHV) trades at $6.80, with a market cap of $699.73M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn